The company will eliminate the Chief Scientific Officer position effective June 1, 2026. Dr. Christian Heidbreder will transition to an advisory role until his termination on December 31, 2026. Shareholders re-elected all eight director nominees at the May 13, 2026, annual meeting. Stockholders approved the advisory vote on executive compensation and ratified the appointment of PwC as the independent auditor for 2026. The company confirmed it will continue to hold annual 'say-on-pay' votes.